Artiva Biotherapeutics (ARTV) Times Interest Earned (2023 - 2026)
Artiva Biotherapeutics' (ARTV) quarterly Times Interest Earned came in at -$2.09 in Q1 2026, down 55.98% year-on-year from -$4.75 in Q1 2025, and up 96.07% on a QoQ basis from -$53.23 in Q4 2025.
Artiva Biotherapeutics (ARTV) Times Interest Earned (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Times Interest Earned data on file, last reported at -$2.09 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 55.98% year-over-year to -$2.09 in Q1 2026; TTM through Mar 2026 was -$7.88, a 73.86% decrease from a year earlier, with the FY2025 full-year figure at -$23.15, down 144.94% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$2.09, up from -$53.23 in the prior quarter.
- Over the last five years, Times Interest Earned for ARTV reached as high as -$1.06 in Q3 2024 and fell as low as -$55.93 in Q4 2023.
- Historically, Times Interest Earned has averaged -$14.6 across 4 years, with a median of -$2.09 in 2026.
- Across the five-year window, Times Interest Earned surged 95.41% in 2024 and slumped 1974.3% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$55.93 in 2023, then jumped by 95.41% to -$2.57 in 2024, then slumped by 1974.3% to -$53.23 in 2025, then soared by 96.07% to -$2.09 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$2.09 in Q1 2026, -$53.23 in Q4 2025, and -$12.45 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Artiva Biotherapeutics | 249.99 Mn | 249.99 Mn | - | -2.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.09 |
| Dec 31, 2025 | -53.23 |
| Sep 30, 2025 | -12.45 |
| Jun 30, 2025 | -1.47 |
| Mar 31, 2025 | -1.34 |
| Dec 31, 2024 | -2.57 |
| Sep 30, 2024 | -1.06 |
| Jun 30, 2024 | -1.29 |
| Dec 31, 2023 | -55.93 |